InsiderTrades

Form 4 for MRK Merck & Co.

Accepted 2026-05-01 17:43:51 ET · period of report 2026-04-29 · accession 0000310158-26-000086 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X Filed Traded Ticker Insider Title Type Price Qty Owned ΔOwn Value
D 2026-05-01 17:43 2026-04-29 MRK Zachary Jennifer EVP, GC M - OptEx $110.03 +2,951 72.4K +4% +$324.7K
D 2026-05-01 17:43 2026-04-29 MRK Zachary Jennifer EVP, GC F - Tax $110.03 -1,454 70.9K -2% -$160.0K
D 2026-05-01 17:43 2026-04-29 MRK Zachary Jennifer EVP, GC M - OptEx $0.00 -2,951 5,903 -33% $0

Purchase Sale Sale after option exercise All abbreviations

Every reported transaction

#TableSecurityDateCodeA/DSharesPriceOwned afterOwnExercise / expiryUnderlyingFootnotes
1 Common Common Stock 2026-04-29 M A 2,951 $110.03 72,351.25 D — —
2 Common Common Stock 2026-04-29 F D 1,454 $110.03 70,897.25 D — —
3 Derivative Restricted Stock Unit 2026-04-29 M D 2,951 $0.00 5,903 D — · 2026-04-29 to 2028-04-29 2,951 Common Stock (F1) Each restricted stock unit represents a contingent right to receive one share of Merck & Co., Inc. common stock. (F2) These restricted stock units vest and are distributed as shares of Merck & Co., Inc. common stock in three equal installments on 4/29/2026, 4/29/2027 and 4/29/2028.